J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naaber, P.
Right arrow Articles by Mikelsaar, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naaber, P.
Right arrow Articles by Mikelsaar, M.
Agricola
Right arrow Articles by Naaber, P.
Right arrow Articles by Mikelsaar, M.
J Med Microbiol 53 (2004), 551-554; DOI: 10.1099/jmm.0.45595-0
© 2004 Society for General Microbiology
ISSN 0022-2615

Inhibition of Clostridium difficile strains by intestinal Lactobacillus species

Paul Naaber, Imbi Smidt, Jelena Stsepetova, Tatjana Brilene, Heidi Annuk and Marika Mikelsaar

Department of Microbiology, University of Tartu, Ravila 19, 40411, Tartu, Estonia

Correspondence Paul Naaber paul.naaber{at}kliinikum.ee

Received January 12, 2004
Accepted January 27, 2004

Indigenous intestinal microflora (including lactobacilli) has an important role in protection against Clostridium difficile infection. To assess in vitro interaction between lactobacilli and C. difficile, antagonistic activity of 50 intestinal Lactobacillus spp. strains against 23 pathogenic C. difficile strains was determined. Phenotypic properties of C. difficile strains [production of short-chain fatty acids (SCFAs) and toxin A, and antimicrobial susceptibility] and lactobacilli (production of SCFAs and H2O2) were investigated. Five lactobacilli (Lactobacillus paracasei and Lactobacillus plantarum species) were antagonistic to all C. difficile strains, 18 were antagonistic to some C. difficile strains and 27 showed no antagonistic activity. This antagonistic activity was strain-specific and seemed to correlate with H2O2 and lactic acid production. C. difficile strains that were more sensitive to lactobacilli (n = 9) usually produced higher toxin levels and more SCFAs, and were more resistant to antibiotics, than strains that were resistant to lactobacilli (n = 14). Compatibility of C. difficile strain properties (resistance to lactobacilli or antibiotics) with intestinal microecological conditions (e.g. presence of antagonistic lactobacilli, concentration of antibiotics) may determine expression of disease.


Abbreviation: SCFA, short-chain fatty acid.




This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
J. Halsey
Current and future treatment modalities for Clostridium difficile-associated disease
Am. J. Health Syst. Pharm., April 15, 2008; 65(8): 705 - 715.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
M. K. Keel and J. G. Songer
The Comparative Pathology of Clostridium difficile-associated Disease
Vet. Pathol., May 1, 2006; 43(3): 225 - 240.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2004 Society for General Microbiology.